Dillon & Associates Inc Danaher Corp Transaction History

Dillon & Associates Inc

  • $688 Million
  • Q2 2024

A detailed history of Dillon & Associates Inc transactions in Danaher Corp stock. As of the latest transaction made, Dillon & Associates Inc holds 48,176 shares of DHR stock, worth $13.4 Million. This represents 1.75% of its overall portfolio holdings.

Number of Shares
48,176
Previous 47,853 0.67%
Holding current value
$13.4 Million
Previous $12 Million 0.68%
% of portfolio
1.75%
Previous 1.88%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024
BUY
$235.51 - $267.98 $76,069 - $86,557
323 Added 0.67%
48,176 $12 Million
Q1 2024

Apr 30, 2024
BUY
$224.58 - $256.19 $57,941 - $66,097
258 Added 0.54%
47,853 $12 Million
Q4 2023

Feb 08, 2024
BUY
$185.1 - $233.13 $285,979 - $360,185
1,545 Added 3.36%
47,595 $11 Million
Q3 2023

Nov 13, 2023
SELL
$233.08 - $265.59 $2,330 - $2,655
-10 Reduced 0.02%
46,050 $11.4 Million
Q2 2023

Aug 08, 2023
SELL
$224.99 - $256.14 $473,828 - $539,430
-2,106 Reduced 4.37%
46,060 $11.1 Million
Q1 2023

May 02, 2023
SELL
$239.75 - $277.0 $267,081 - $308,578
-1,114 Reduced 2.26%
48,166 $12.1 Million
Q1 2023

May 01, 2023
SELL
$239.75 - $277.0 $22,776 - $26,315
-95 Reduced 0.19%
49,280 $12.4 Million
Q4 2022

Feb 06, 2023
SELL
$241.42 - $282.29 $35,971 - $42,061
-149 Reduced 0.3%
49,375 $13.1 Million
Q3 2022

Nov 08, 2022
SELL
$247.06 - $1507.4 $19,764 - $120,592
-80 Reduced 0.16%
49,524 $12.8 Million
Q2 2022

Jul 26, 2022
BUY
$237.11 - $299.66 $711 - $898
3 Added 0.01%
49,604 $12.6 Million
Q1 2022

May 06, 2022
BUY
$257.27 - $315.76 $82,583 - $101,358
321 Added 0.65%
49,601 $14.5 Million
Q4 2021

Feb 14, 2022
SELL
$292.08 - $329.01 $59,876 - $67,447
-205 Reduced 0.41%
49,280 $16.2 Million
Q3 2021

Oct 28, 2021
SELL
$272.21 - $332.43 $16,060 - $19,613
-59 Reduced 0.12%
49,485 $15 Million
Q2 2021

Aug 02, 2021
SELL
$225.08 - $271.69 $48,617 - $58,685
-216 Reduced 0.43%
49,544 $13.3 Million
Q1 2021

May 10, 2021
SELL
$212.38 - $245.9 $63,501 - $73,524
-299 Reduced 0.6%
49,760 $11.2 Million
Q4 2020

Feb 12, 2021
SELL
$212.5 - $245.46 $58,437 - $67,501
-275 Reduced 0.55%
50,059 $11.1 Million
Q3 2020

Nov 06, 2020
BUY
$177.16 - $215.33 $177 - $215
1 Added 0.0%
50,334 $10.8 Million
Q2 2020

Jul 28, 2020
BUY
$128.7 - $176.83 $7,850 - $10,786
61 Added 0.12%
50,333 $8.91 Million
Q1 2020

May 07, 2020
SELL
$121.39 - $169.05 $4,127 - $5,747
-34 Reduced 0.07%
50,272 $6.94 Million
Q4 2019

Feb 03, 2020
SELL
$133.47 - $153.48 $1,735 - $1,995
-13 Reduced 0.03%
50,306 $7.7 Million
Q3 2019

Oct 25, 2019
BUY
$135.4 - $146.47 $47,660 - $51,557
352 Added 0.7%
50,319 $7.25 Million
Q2 2019

Jul 22, 2019
BUY
$124.88 - $143.73 $992,046 - $1.14 Million
7,944 Added 18.9%
49,967 $7.15 Million
Q1 2019

May 07, 2019
BUY
$97.62 - $132.29 $262,695 - $355,992
2,691 Added 6.84%
42,023 $5.55 Million
Q4 2018

Feb 14, 2019
SELL
$94.85 - $109.54 $12,615 - $14,568
-133 Reduced 0.34%
39,332 $4.05 Million
Q3 2018

Nov 14, 2018
BUY
$98.13 - $108.9 $98 - $108
1 Added 0.0%
39,465 $4.3 Million
Q2 2018

Aug 08, 2018
BUY
$96.1 - $103.24 $192 - $206
2 Added 0.01%
39,464 $3.91 Million
Q1 2018

May 08, 2018
BUY
$92.16 - $103.8 $42,946 - $48,370
466 Added 1.19%
39,462 $3.87 Million
Q4 2017

Feb 08, 2018
SELL
$85.26 - $94.62 $42,459 - $47,120
-498 Reduced 1.26%
38,996 $3.63 Million
Q3 2017

Nov 13, 2017
BUY
$79.29 - $88.45 $12,844 - $14,328
162 Added 0.41%
39,494 $3.4 Million
Q2 2017

Aug 09, 2017
BUY
N/A
39,332
39,332 $3.3 Million

Others Institutions Holding DHR

# of Institutions
2,390
Shares Held
563M
Call Options Held
3.94M
Put Options Held
4.1M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $202B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Dillon & Associates Inc Portfolio

Follow Dillon & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dillon & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dillon & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email